Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America

[pdf-embedder url=”https://hsctwarriors.org/wp-content/uploads/2023/02/MS-health-economics.pdf”]